Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin pharmacokinetics in epithelial lining fluid and plasma in mechanically ventilated patients with MDR/XDR Gram-negative pneumonia or tracheobronchitis
2017-002269-23Phase 2Terminated
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of colistimethate sodium in ventilator-associated pneumonia (VAP), ventilator-associated tracheobronchitis (VAT), Healthcare-associated pneumonia (HCAP) and 2 more (2 arms), sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Primary endpoints: Pharmacokinetic parameters in epithelial lining fluid and plasma and Safety. Started Jun 2021; status: terminated.
02
Drugs
colistimethate sodium
03
Conditions
ventilator-associated pneumonia (VAP)ventilator-associated tracheobronchitis (VAT)Healthcare-associated pneumonia (HCAP)hospital-acquired pneumonia (HAP)Gram-negative bacterial infection
Beyond the preview
Go deeper on 2017-002269-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002269-23.